Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum

Cell Transplantation

Volumn 23, Issue 11, 2014, Pages 1407-1423

  Fink, Kyle D ^a,b,c,d,e   Rossignol, Julien ^a,f   Lu, Ming ^a,g   Lévêque, Xavier ^a,b,c,e,g   Hulse, Travis D ^a   Crane, Andrew T ^a   Nerriere Daguin, Veronique ^b,c,e   Wyse, Robert D ^a   Starski, Phillip A ^a   Schloop, Matthew T ^a   Dues, Dylan J ^a   Witte, Steve J ^a   Song, Cheng ^a   Vallier, Ludovic ^h   Nguyen, Tuan H ^b,c,d,e   Naveilhan, Philippe ^b,c,e,i   Anegon, Ignacio ^b,c,e   Lescaudron, Laurent ^b,c,d,e   Dunbar, Gary L ^a,f,g  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITÉ DE NANTES   (France)

^c INSERM   (France)

^d Universite de Nantes   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f Children's Hospital of Michigan   (United States)

^g Field Neurosciences Institute   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ INSERM   (France)

Author keywords

Adenovirus; Induced pluripotent stem cells (iPSCs); Neuronal differentiation; Stem cell; Transplantation

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; FIBROBLAST; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; LENTIVIRINAE; MALE; NERVE CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION; ADENOVIRIDAE; ANIMAL; CYTOLOGY; GENETIC TRANSFECTION; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; SURGERY; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR REPROGRAMMING; CORPUS STRIATUM; INDUCED PLURIPOTENT STEM CELLS; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TRANSFECTION;

EID: 84908116860     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368913X670958     Document Type: Article

References (48)

1. Aoi, T.; Yae, K.; Nakagawa, M.; Ichisaka, T.; Okita, K.; Takahashi, K.; Chiba, T.; Yamanaka, S. Generation of pluri-potent stem cells from adult mouse liver and stomach cells. Science 321:699-702; 2008.
2. Araki, R.; Uda, M.; Hoki, Y.; Sunayama, M.; Nakamura, M.; Ando, S.; Sugiura, M.; Ideno, H.; Shimada, A.; Nifuji, A.; Abe, M. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494:100-104; 2013.
3. Aubry, L.; Bugi, A.; Lefort, N.; Rousseau, F.; Peschanski, M.; Perrier, A. L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 105:16707-16712; 2008.
4. Bachoud-Lévi, A.-C. Neural grafts in Huntington’s disease: Viability after 10 years. Lancet Neurol. 8:979-981; 2009
5. Blau, H. M.; Chiu, C. P.; Webster, C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32:1171-1180; 1983.
6. Boyd, A. S.; Rodrigues, N. P.; Lui, K. O.; Fu, X.; Xu, Y. Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells 30:797-803; 2012.
7. Briggs, R.; King, T. J. Transplantation of living nuclei from blastula cells into enucleated frogs’ eggs. Proc. Natl. Acad. Sci. USA 38:455-463; 1952.
8. Brundin, P.; Barker, R. A.; Parmar, M. Neural grafting in Parkinson’s disease: Problems and possibilities. Prog. Brain Res. 184:265-294; 2010.
9. Carey, B. W.; Markoulaki, S.; Hanna, J.; Saha, K.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 106:157-162; 2009.
10. Chang, M.-Y.; Kim, D.; Kim, C.-H.; Kang, H.-C.; Yang, E.; Moon, J.-I.; Ko, S.; Park, J.; Park, K.-S.; Lee, K.-A.; Hwang, D.-Y.; Chung, Y.; Lanza, R.; Kim, K.-S. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One 5:e9838; 2010.
11. Chin, M. H.; Pellegrini, M.; Plath, K.; Lowry, W. E. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7:263-269; 2010.
12. Fändrich, F.; Lin, X.; Chai, G. X.; Schulze, M.; Ganten, D.; Bader, M.; Holle, J.; Huang, D.-S.; Parwaresch, R.; Zavazava, N.; Binas, B. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat. Med. 8:171-178; 2002.
13. Fink, K. D.; Rossignol, J.; Crane, A. T.; Hulse, T. D.; Leveque, X.; Wyse, R.; Dues, D. J.; Huffman, L. D.; Moore, A. C.; Story, D. T.; Dejonge, R. E.; Lu, M.; Lescaudron, L.; Dunbar, G. L. Transplantation of adenovirus-generated induced pluripotent stem cells into Huntington’s disease striatum: Analysis of survival, differentiation, and recovery of function. Cell Transplant. 22:902; 2013.
14. Freed, C. R.; Breeze, R. E.; Rosenberg, N. L.; Schneck, S. A.; Wells, T. H.; Barrett, J. N.; Grafton, S. T.; Mazziotta, J. C.; Eidelberg, D.; Rottenberg, D. A. Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson’s disease. Prog. Brain Res. 82:715-721; 1990.
15. Giorgetti, A.; Montserrat, N.; Aasen, T.; Gonzalez, F.; Rodríguez-Pizà, I.; Vassena, R.; Raya, A.; Boué, S.; Barrero, M. J.; Corbella, B. A.; Torrabadella, M.; Veiga, A.; Izpisua Belmonte, J. C. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5:353-357; 2009.
16. Gonzalez, F.; Barragan Monasterio, M.; Tiscornia, G.; Montserrat Pulido, N.; Vassena, R.; Batlle Morera, L.; Rodriguez Piza, I.; Izpisua Belmonte, J. C. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviralpolycistronic vector. Proc. Natl. Acad. Sci. USA 106:8918-8922; 2009.
17. Heng, J.-C. D.; Feng, B.; Han, J.; Jiang, J.; Kraus, P.; Ng, J.-H.; Orlov, Y. L.; Huss, M.; Yang, L.; Lufkin, T.; Lim, B.; Ng, H.-H. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6:167-174; 2010.
18. Ho, R.; Chronis, C.; Plath, K. Mechanistic insights into reprogramming to induced pluripotency. J. Cell. Physiol. 226:868-878; 2011.
19. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D. A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26:1269-1275; 2008.
20. Jia, F.; Wilson, K. D.; Sun, N.; Gupta, D. M.; Huang, M.; Li, Z.; Panetta, N. J.; Chen, Z. Y.; Robbins, R. C.; Kay, M. A.; Longaker, M. T.; Wu, J. C. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7:197-199; 2010.
21. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-775; 2009.
22. Kim, J. B.; Zaehres, H.; Wu, G.; Gentile, L.; Ko, K.; Sebastiano, V.; Araúzo-Bravo, M. J.; Ruau, D.; Han, D. W.; Zenke, M.; Schöler, H. R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454:646-650; 2008.
23. Labandeira-Garcia, J. L.; Wictorin, K.; Cunningham, Jr., E. T.; Björklund, A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience 42:407-426; 1991.
24. Lescaudron, L.; Boyer, C.; Bonnamain, V.; Fink, K. D.; Lévêque, X.; Rossignol, J.; Nerrière-Daguin, V.; Malouet, A. C.; Lelan, F.; Dey, N. D.; Michel-Monigadon, D.; Lu, M.; Neveu, I.; von Hörsten, S.; Naveilhan, P.; Dunbar, G. L. Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases. Methods Mol. Biol. 879:147-164; 2012.
25. Li, W.; Wei, W.; Zhu, S.; Zhu, J.; Shi, Y.; Lin, T.; Hao, E.; Hayek, A.; Deng, H.; Ding, S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19; 2009.
26. Lister, R.; Pelizzola, M.; Kida, Y. S.; Hawkins, R. D.; Nery, J. R.; Hon, G.; Antosiewicz-Bourget, J.; O’Malley, R.; Castanon, R.; Klugman, S.; Downes, M.; Yu, R.; Stewart, R.; Ren, B.; Thomson, J. A.; Evans, R. M.; Ecker, J. R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73; 2011.
27. Lowry, W. E.; Richter, L.; Yachechko, R.; Pyle, A. D.; Tchieu, J.; Sridharan, R.; Clark, A. T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105:2883-2888; 2008.
28. Ma, L.; Liu, Y.; Zhang, S.-C. Directed differentiation of dopamine neurons from human pluripotent stem cells. Methods Mol. Biol. 767:411-418; 2011.
29. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26:101-106; 2008.
30. Nguyen, T. H.; Bellodi-Privato, M.; Aubert, D.; Pichard, V.; Myara, A.; Trono, D.; Ferry, N. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. Mol. Ther. 12:852-859; 2005.
31. Niibe, K.; Kawamura, Y.; Araki, D.; Morikawa, S.; Miura, K.; Suzuki, S.; Shimmura, S.; Sunabori, T.; Mabuchi, Y.; Nagai, Y.; Nakagawa, T.; Okano, H.; Matsuzaki, Y. Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS One 6:e17610; 2011.
32. Nussbaum, J.; Minami, E.; Laflamme, M. A.; Virag, J. A. I.; Ware, C. B.; Masino, A.; Muskheli, V.; Pabon, L.; Reinecke, H.; Murry, C. E. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J. 21:1345-1357; 2007.
33. Ohnuki, M.; Takahashi, K.; Yamanaka, S. Generation and characterization of human induced pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 9A:4A.2.1-4A.2.25; 2009.
34. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline competent induced pluripotent stem cells. Nature 448:313-317; 2007.
35. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953; 2008.
36. Pearl, J. I.; Kean, L. S.; Davis, M. M.; Wu, J. C. Pluripotent stem cells: Immune to the immune system? Sci. Transl. Med. 4:164 ps 25; 2012.
37. Peng, J.; Zeng, X. The role of induced pluripotent stem cells in regenerative medicine: Neurodegenerative diseases. Stem Cell Res.Ther. 2:32; 2011.
38. Rossignol, J.; Boyer, C.; Thinard, R.; Remy, S.; Dugast, A.-S.; Dubayle, D.; Dey, N. D.; Boeffard, F.; Delecrin, J.; Heymann, D.; Vanhove, B.; Anegon, I.; Naveilhan, P.; Dunbar, G. L.; Lescaudron, L. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J. Cell. Mol. Med. 13:2547-2558; 2009.
39. Sommer, C. A.; Stadtfeld, M.; Murphy, G. J.; Hochedlinger, K.; Kotton, D. N.; Mostoslavsky, G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27:543-549; 2009.
40. Stadtfeld, M.; Apostolou, E.; Akutsu, H.; Fukuda, A.; Follett, P.; Natesan, S.; Kono, T.; Shioda, T.; Hochedlinger, K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465:175-181; 2010.
41. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322:945-949; 2008.
42. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676; 2006.
43. Tan, K. Y.; Eminli, S.; Hettmer, S.; Hochedlinger, K.; Wagers, A. J. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One 6:e26406; 2011.
44. Wernig, M.; Lengner, C. J.; Hanna, J.; Lodato, M. A.; Steine, E.; Foreman, R.; Staerk, J.; Markoulaki, S.; Jaenisch, R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26:916-924; 2008.
45. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-celllike state. Nature 448: 318-324; 2007.
46. Yamanaka, S.; Blau, H. M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465:704-712; 2010.
47. Zhang, Y.; Yao, L.; Yu, X.; Ou, J.; Hui, N.; Liu, S. A poor imitation of a natural process: Acall to reconsider the iPSC engineering technique. Cell Cycle 11:4536-4544; 2012.
48. Zhao, T.; Zhang, Z.-N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474:212-215; 2011.